Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway
Jiwei Zhang, Shengli Li, Jianian Zhang, Wen Zhang, Jiawen Jiang, Hao Wu, Enjiang Wu, Yutao Feng, Li Yang, Zhe Li
Topics & Concepts
Prostate cancerCancer researchDocetaxelKinaseTANK-binding kinase 1GSK-3StingBlockadeBiologyPhosphorylationSignal transductionBystander effectMedicineCancerInternal medicineImmunologyProtein kinase AReceptorCell biologyMAP kinase kinase kinaseAerospace engineeringEngineeringCancer-related molecular mechanisms researchinterferon and immune responsesRNA Research and Splicing